XML 23 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Treasury stock
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Beginning of period (in shares) at Sep. 30, 2017   33,464,000          
Exercise of stock options and vesting of other stock awards   633,000          
Treasury shares purchased (in shares)   (2,259,000)          
End of period (in shares) at Sep. 29, 2018   31,838,000          
Beginning of period at Sep. 30, 2017 $ 1,025,939 $ 519 $ 555,297 $ (574,104) $ 1,049,206   $ (4,979)
Exercise of stock options and vesting of other stock awards   7          
Stock-based compensation expense     17,981        
Exercise of stock options and vesting of other stock awards, including tax benefits     8,210        
Treasury shares purchased       (137,034)      
Net income 13,040       13,040    
Other comprehensive income (loss) (7,000)           (7,000)
End of period at Sep. 29, 2018 $ 921,143 $ 526 581,488 (711,138) 1,062,246   (11,979)
Cumulative effect adjustment for adoption of new accounting pronouncements (1) [1]           $ 7,815  
Exercise of stock options and vesting of other stock awards   350,000          
Treasury shares purchased (in shares)   (3,184,000)          
End of period (in shares) at Sep. 28, 2019 29,004,000 29,004,000          
Exercise of stock options and vesting of other stock awards   $ 3          
Stock-based compensation expense     21,335        
Exercise of stock options and vesting of other stock awards, including tax benefits     (5,422)        
Treasury shares purchased       (182,109)      
Net income $ 108,616       108,616    
Other comprehensive income (loss) (5,805)           (5,805)
End of period at Sep. 28, 2019 $ 865,576 $ 529 597,401 (893,247) 1,178,677   (17,784)
Cumulative effect adjustment for adoption of new accounting pronouncements (1) [1]           $ (1,077)  
Exercise of stock options and vesting of other stock awards   608,000          
Treasury shares purchased (in shares)   (610,000)          
End of period (in shares) at Oct. 03, 2020 29,002,000 29,002,000          
Exercise of stock options and vesting of other stock awards   $ 6          
Stock-based compensation expense     24,280        
Exercise of stock options and vesting of other stock awards, including tax benefits     (117)        
Treasury shares purchased       (41,392)      
Net income $ 117,479       117,479    
Other comprehensive income (loss) 12,725           12,725
End of period at Oct. 03, 2020 $ 977,480 $ 535 $ 621,564 $ (934,639) $ 1,295,079   $ (5,059)
[1] See Note 1, "Description of Business and Significant Accounting Policies," for a discussion of recently adopted accounting pronouncements.